search
Back to results

Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized Controlled Trial. (DOLCE)

Primary Purpose

Cholelithiasis

Status
Not yet recruiting
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Laparoscopic Cholecystectomy
Sponsored by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cholelithiasis focused on measuring Laparoscopic Cholecystectomy, quality of life

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult (from 18 to 70 years old) patients presenting for gallstone disease surgery (symptomatic cholelithiasis, according to the Rome criteria ) confirmed by ultrasound living less than 50 km from the hospital (the day-care protocol specifies that an adult must be available to accompany the patient home and stay there overnight) were considered for entry into the trial.

Exclusion Criteria:

  • Refusing of informed consent
  • Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient)
  • Patients with contraindication to be operated with LC
  • Patients with an American Society of Anesthesiologists (ASA) score of III or more.
  • BMI >35 kg/m2
  • Asthma
  • extensive previous abdominal surgery
  • patients with a clinical suspicion of common bile duct stones or a history of acute cholecystitis or pancreatitis, calcified gallbladder.

Sites / Locations

  • St Orsola-Malpighi Hospital - University of Bologna

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

overnight stay group

day-care Group

Arm Description

Group of patients who rests at least one night in Hospital

Group of patients who is discharged tha same day of operation

Outcomes

Primary Outcome Measures

Evidence of better quality of life revealed by SF-36 test

Secondary Outcome Measures

Readmissions, Postoperative pain, Wound infections, Intraoperative and postoperative complications, Duration of operation(minutes), Return to normal activity (days) defined as time until return to full activity, work, school or sport.

Full Information

First Posted
January 19, 2010
Last Updated
July 19, 2022
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
search

1. Study Identification

Unique Protocol Identification Number
NCT01052727
Brief Title
Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized Controlled Trial.
Acronym
DOLCE
Official Title
DOLCE Study: Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized, Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
DOLCE Study: Day-care versus Overnight-stay Laparoscopic Cholecystectomy randomized, controlled trial. The aim of this study was to evaluate the feasibility, safety and patient acceptance of outpatient LC in Italy. In particular this randomized clinical trial will use the SF-36 as powerful instrument to compare quality of life and global health status after LC performed as a day-care procedure or with an overnight stay. Particular attention is taken to answer to the following methodological issues: concealed randomization, ITT analysis, number of eligible, excluded and refusing patients clearly stated.
Detailed Description
The DOLCE study project is a prospective, randomised, open label, comparison of LC performed either as a day-care procedure or with overnight stay with symptomatic gallstones. The aim of this study was to evaluate the feasibility, safety and patient acceptance of outpatient LC in Italy. In particular this randomized clinical trial will use the SF-36 as powerful instrument to compare quality of life and global health status after LC performed as a day-care procedure or with an overnight stay. The outcome measured are the following: quality of life and health status admissions and readmissions; postoperative pain (SVS, number of analgesic doses); wound infections (rate); intraoperative and postoperative complications duration of operation (minutes), defined as operating time, anesthesia time, or operating room time; return to normal activity (days), subdivided in: time until return to full activity, work, or sport; The instrument used to assess quality of life and heath status will be SF-36. The study will be performed in a Day-Surgery Unit where an over-night stay is possible in case of complications. INCLUSION AND EXCLUSION CRITERIA Inclusion criteria are: • Adult (from 18 to 70 years old) patients presenting for gallstone disease surgery (symptomatic cholelithiasis, according to the Rome criteria ) confirmed by ultrasound living less than 50 km from the hospital (the day-care protocol specifies that an adult must be available to accompany the patient home and stay there overnight) were considered for entry into the trial. Exclusion criteria Refusing of informed consent Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient) Patients with contraindication to be operated with LC Patients with an American Society of Anesthesiologists (ASA) score of III or more. BMI >35 kg/m2 Asthma extensive previous abdominal surgery patients with a clinical suspicion of common bile duct stones or a history of acute cholecystitis or pancreatitis, calcified gallbladder.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholelithiasis
Keywords
Laparoscopic Cholecystectomy, quality of life

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
overnight stay group
Arm Type
Other
Arm Description
Group of patients who rests at least one night in Hospital
Arm Title
day-care Group
Arm Type
Other
Arm Description
Group of patients who is discharged tha same day of operation
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic Cholecystectomy
Primary Outcome Measure Information:
Title
Evidence of better quality of life revealed by SF-36 test
Time Frame
before surgery, 7 days after surgery, 30 days after surgery
Secondary Outcome Measure Information:
Title
Readmissions, Postoperative pain, Wound infections, Intraoperative and postoperative complications, Duration of operation(minutes), Return to normal activity (days) defined as time until return to full activity, work, school or sport.
Time Frame
prior to surgery, 7 days after surgery and 30 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (from 18 to 70 years old) patients presenting for gallstone disease surgery (symptomatic cholelithiasis, according to the Rome criteria ) confirmed by ultrasound living less than 50 km from the hospital (the day-care protocol specifies that an adult must be available to accompany the patient home and stay there overnight) were considered for entry into the trial. Exclusion Criteria: Refusing of informed consent Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient) Patients with contraindication to be operated with LC Patients with an American Society of Anesthesiologists (ASA) score of III or more. BMI >35 kg/m2 Asthma extensive previous abdominal surgery patients with a clinical suspicion of common bile duct stones or a history of acute cholecystitis or pancreatitis, calcified gallbladder.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Luca Ansaloni, MD
Phone
0039 0516363235
Email
luca.ansaloni@aosp.bo.it
First Name & Middle Initial & Last Name or Official Title & Degree
Alessandro Dazzi, MD
Phone
0039 0516363721
Email
alled78@yahoo.it
Facility Information:
Facility Name
St Orsola-Malpighi Hospital - University of Bologna
City
Bologna
ZIP/Postal Code
40100
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luca Ansaloni, MD
Phone
0039 0516363235
Email
luca.ansaloni@aosp.bo.it
First Name & Middle Initial & Last Name & Degree
Luca Ansaloni, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
18398648
Citation
Ahmad NZ, Byrnes G, Naqvi SA. A meta-analysis of ambulatory versus inpatient laparoscopic cholecystectomy. Surg Endosc. 2008 Sep;22(9):1928-34. doi: 10.1007/s00464-008-9867-2. Epub 2008 Apr 9.
Results Reference
background
PubMed Identifier
18196561
Citation
Gurusamy K, Junnarkar S, Farouk M, Davidson BR. Meta-analysis of randomized controlled trials on the safety and effectiveness of day-case laparoscopic cholecystectomy. Br J Surg. 2008 Feb;95(2):161-8. doi: 10.1002/bjs.6105.
Results Reference
background

Learn more about this trial

Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized Controlled Trial.

We'll reach out to this number within 24 hrs